• Login
    Search 
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Search
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 50

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Isolation of a Monoclonal Antibody That Targets the Alpha-2 Helix of gp120 and Represents the Initial Autologous Neutralizing-Antibody Response in an HIV-1 Subtype C-Infected Individual. 

    Gray, Elin S.; Moody, M. Anthony.; Wibmer, Constantinos Kurt.; Chen, Xi.; Marshall, Dawn.; Amos, Joshua.; Moore, Penny L.; Foulger, Andrew.; Yu, Jae-Sung.; Lambson, Bronwen E.; Abdool Karim, Salim Safurdeen.; Whitesides, John.; Tomaras, Georgia D.; Haynes, Barton F.; Morris, Lynn.; Liao, Hua-Xin. (American Society for Microbiology., 2011-05-12)
    The C3-V4 region is a major target of autologous neutralizing antibodies in HIV-1 subtype C infection. We previously identified a Center for AIDS Program of Research in South Africa (CAPRISA) participant, CAP88, who ...
    Thumbnail

    Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. 

    Archary, Derseree.; Rong, Rong.; Gordon, Michelle Lucille.; Boliar, Saikat.; Madiga, Maphuti C.; Gray, Elin S.; Dugast, Anne-Sophie.; Hermanus, Tandile.; Goulder, Philip.; Coovadia, Hoosen Mahomed.; Werner, Lise.; Morris, Lynn.; Alter, Galit.; Derdeyn, Cynthia A.; Ndung'u, Thumbi. (Elsevier., 2012-11-25)
    Neutralizing (nAbs) and high affinity binding antibodies may be critical for an efficacious HIV-1 vaccine. We characterized virus-specific nAbs and binding antibody responses over 21 months in eight HIV-1 subtype C chronically ...
    Thumbnail

    Initial B-Cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. 

    Tomaras, Georgia D.; Yates, Nicole L.; Liu, Pinghuang.; Qin, Li.; Fouda, Genevieve G.; Chavez, Leslie L.; Decamp, Allan C.; Parks, Robert J.; Ashley, Vicki C.; Lucas, Judith T.; Cohen, Myron.; Eron, Joseph.; Hick, Charles B.; Liao, Hua-Xin.; Self, Steven G.; Landucci, Gary.; Forthal, Donald N.; Weinhold, Kent J.; Keele, Brandon F.; Hahn, Beatrice H.; Greenberg, Michael L.; Morris, Lynn.; Abdool Karim, Salim Safurdeen.; Blattner, William A.; Montefiori, David C.; Shaw, George M.; Perelson, Alan S.; Haynes, Barton F. (American Society for Microbiology., 2008)
    A window of opportunity for immune responses to extinguish human immunodeficiency virus type 1 (HIV-1) exists from the moment of transmission through establishment of the latent pool of HIV-1-infected cells. A critical ...
    Thumbnail

    High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. 

    Davis, Katie L.; Gray, Elin S.; Moore, Penny L.; Decker, Julie M.; Salomon, Aidy.; Montefiori, David C.; Graham, Barney S.; Keefer, Michael C.; Pinter, Abraham.; Morris, Lynn.; Hahn, Beatrice H.; Shaw, George M. (Elsevier, 2009-03)
    Identifying the earliest neutralizing antibody specificities that are elicited following infection or vaccination by HIV-1 is an important objective of current HIV/AIDS vaccine research. We have shown previously ...
    Thumbnail

    A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences. 

    Jensen, Mark A.; Coetzer, Mia.; Van 't Wout, Angelique B.; Morris, Lynn.; Mullins, James I. (American Society for Microbiology., 2006-05)
    In human immunodeficiency virus type 1 (HIV-1) subtype B infections, the emergence of viruses able to use CXCR4 as a coreceptor is well documented and associated with accelerated CD4 decline and disease progression. However, ...
    Thumbnail

    The development of CD4 binding site antibodies during HIV-1 infection. 

    Lynch, Rebecca M.; Tran, Lillian.; Louder, Mark K.; Schmidt, Stefan D.; Cohen, Myron.; DerSimonian, Rebecca.; Euler, Zelda.; Gray, Elin S.; Abdool Karim, Salim Safurdeen.; Kirchherr, Jennifer.; Montefiori, David C.; Sibeko, Sengeziwe.; Soderberg, Kelly.; Tomaras, Georgia D.; Yang, Zhi-Yong.; Nabel, Gary J.; Schuitemaker, Hanneke.; Morris, Lynn.; Haynes, Barton F.; Mascola, John R. (American Society for Microbiology., 2012-07)
    Broadly neutralizing antibodies to the CD4 binding site (CD4bs) of gp120 are generated by some HIV-1-infected individuals, but little is known about the prevalence and evolution of this antibody response during the course ...
    Thumbnail

    Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes. 

    Wibmer, Constantinos Kurt.; Bhiman, Jinal N.; Gray, Elin S.; Tumba, Nancy L.; Abdool Karim, Salim Safurdeen.; Williamson, Carolyn.; Morris, Lynn.; Moore, Penny L. (Plos., 2013-10-31)
    Identifying the targets of broadly neutralizing antibodies to HIV-1 and understanding how these antibodies develop remain important goals in the quest to rationally develop an HIV-1 vaccine. We previously identified a ...
    Thumbnail

    Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate Human Immunodeficiency Virus Type 1 vaccines. 

    Mascola, John R.; D'Souza, Patricia.; Gilbert, Peter.; Hahn, Beatrice H.; Haigwood, Nancy L.; Morris, Lynn.; Petropoulos, Christos J.; Polonis, Victoria R.; Sarzotti, Marcella.; Montefiori, David C. (American Society for Microbiology., 2005-08)
    No abstract available.
    Thumbnail

    Multiple pathways of escape from HIV broadly cross-neutralizing V2-dependent antibodies. 

    Moore, Penny L.; Sheward, Daniel.; Nonyane, Molati.; Ranchobe, Nthabeleng.; Hermanus, Tandile.; Gray, Elin S.; Abdool Karim, Salim Safurdeen.; Williamson, Carolyn.; Morris, Lynn. (American Society for Microbiology., 2013-02-13)
    Broadly cross-neutralizing (BCN) antibodies are likely to be critical for an effective HIV vaccine. However, the ontogeny of such antibodies and their relationship with autologous viral evolution is unclear. Here, we ...
    Thumbnail

    Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape. 

    Moore, Penny L.; Gray, Elin S.; Wibmer, Constantinos Kurt.; Bhiman, Jinal N.; Nonyane, Molati.; Hermanus, Tandile.; Sheward, Daniel.; Bajimaya, Shringkhala.; Abrahams, Melissa-Rose.; Tumba, Nancy L.; Ping, Li-Hua.; Ngandu, Nobubelo K.; Abdool Karim, Quarraisha.; Abdool Karim, Salim Safurdeen.; Swanstrom, Ronald.; Seaman, Michael S.; Williamson, Carolyn.; Morris, Lynn. (Nature Publishing Group., 2012-11)
    Neutralizing antibodies are likely to play a crucial part in a preventative HIV-1 vaccine. Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been unsuccessful, a minority of individuals ...
    • 1
    • 2
    • 3
    • 4
    • . . .
    • 5

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CommunityBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    Discover

    Author
    Morris, Lynn. (50)
    Abdool Karim, Salim Safurdeen. (38)Moore, Penny L. (28)Williamson, Carolyn. (21)Gray, Elin S. (18)Mascola, John R. (14)Haynes, Barton F. (12)Montefiori, David C. (11)Kwong, Peter D. (10)Mlisana, Koleka Patience. (10)... View MoreSubjectAIDS vaccines. (8)HIV infections--Immunology. (8)Broadly neutralizing antibodies. (7)HIV antibodies. (6)HIV infections--Virology. (5)Neutralizing antibodies. (5)AIDS (Disease)--Vaccines. (4)AIDS Vaccines/immunology. (4)Amino Acid Sequence. (4)Antibodies, Neutralizing/immunology. (4)... View MoreDate Issued2010 - 2017 (40)2005 - 2009 (10)

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV